Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Wulff-Burchfield discussed strategies ...

Prostate cancer is cancer of the prostate gland ... A blood test can measure the level of PSA. The diagram below shows the position of the prostate gland, the bladder and the back passage (rectum).

The stage of a cancer tells you how big it is and how far it has spread. It helps your doctor decide the best treatment for you. The tests and scans you have to diagnose your bladder cancer give some ...

Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder ...

The investigational therapeutic is specially engineered to target and kill bladder cancer cells as well as stimulate an antitumor response. Cretostimogene works in two important ways. It enters ...

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the drug demonstrated benefits in those with a higher-risk form of non ...

Imfinzi is approved for muscle-invasive bladder cancer and is under investigation in various stages and combinations for bladder cancer treatment. Imfinzi plus BCG induction and maintenance therapy ...

PEOPLE WITH BLADDER CANCER IN THE US COULD FILL FENWAY PARK 20 TIMES OVER? THAT’S A STADIUM SIZED REASON TO JOIN US FOR THE WALK TO END BLADDER CANCER ON SATURDAY, MAY 17TH. GOOD MORNING.

(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer.

99% 12-month and 96% 36-month disease-specific survival in papillary NMIBC without CIS. 10-year cystectomy-free status observed in long-term follow-up of Phase 1 trial. Discover how Matt Maley ...